Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Proia TA"'
Autor:
Vasalou C; Clinical Pharmacology & Safety Sciences, Waltham, Massachusetts, USA., Proia TA; Translational Medicine, Waltham, Massachusetts, USA., Kazlauskas L; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Przybyla A; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Sung M; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Mamidi S; AstraZeneca Research & Development, Cambridge, UK., Maratea K; Clinical Pharmacology & Safety Sciences, Waltham, Massachusetts, USA., Griffin M; Clinical Pharmacology & Safety Sciences, Waltham, Massachusetts, USA., Sargeant R; Clinical Pharmacology & Safety Sciences, Cambridge, UK., Urosevic J; AstraZeneca Research & Development, Cambridge, UK., Rosenbaum AI; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, South San Francisco, California, USA., Yuan J; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, South San Francisco, California, USA., Aluri KC; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Ramsden D; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Hariparsad N; AstraZeneca Research & Development, Waltham, Massachusetts, USA., Jones RDO; AstraZeneca Research & Development, Cambridge, UK., Mettetal JT; AstraZeneca Research & Development, Waltham, Massachusetts, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jun; Vol. 13 (6), pp. 994-1005. Date of Electronic Publication: 2024 Mar 26.
Autor:
Pore N; AstraZeneca, Gaithersburg, Maryland., Wu S; AstraZeneca, Gaithersburg, Maryland., Standifer N; AstraZeneca, Gaithersburg, Maryland., Jure-Kunkel M; AstraZeneca, Gaithersburg, Maryland., de Los Reyes M; AstraZeneca, Gaithersburg, Maryland., Shrestha Y; AstraZeneca, Gaithersburg, Maryland., Halpin R; AstraZeneca, Gaithersburg, Maryland., Rothstein R; AstraZeneca, Gaithersburg, Maryland., Mulgrew K; AstraZeneca, Gaithersburg, Maryland., Blackmore S; AstraZeneca, Gaithersburg, Maryland., Martin P; AstraZeneca, Gaithersburg, Maryland., Meekin J 3rd; AstraZeneca, Gaithersburg, Maryland., Griffin M; AstraZeneca, Waltham, Massachusetts., Bisha I; AstraZeneca, Munich, Germany., Proia TA; AstraZeneca, Waltham, Massachusetts., Miragaia RJ; AstraZeneca, Cambridge, United Kingdom., Herbst R; AstraZeneca, Gaithersburg, Maryland., Gupta A; AstraZeneca, Gaithersburg, Maryland., Abdullah SE; AstraZeneca, Gaithersburg, Maryland., Raja R; AstraZeneca, Gaithersburg, Maryland., Frigault MM; AstraZeneca, Gaithersburg, Maryland., Barrett JC; AstraZeneca, Gaithersburg, Maryland., Dennis PA; AstraZeneca, Gaithersburg, Maryland., Ascierto ML; AstraZeneca, Gaithersburg, Maryland. ml.ascierto@gmailcom michael.oberst@astrazeneca.com., Oberst MD; AstraZeneca, Gaithersburg, Maryland. ml.ascierto@gmailcom michael.oberst@astrazeneca.com.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Nov; Vol. 11 (11), pp. 2828-2845. Date of Electronic Publication: 2021 Jul 06.
Autor:
Carnevalli LS; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom. Larissa.Carnevalli@astrazeneca.com Simon.T.Barry@astrazeneca.com., Taylor MA; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., King M; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Coenen-Stass AML; Translational Medicine, Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Hughes AM; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Bell S; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Proia TA; Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Wang Y; Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Ramos-Montoya A; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Wali N; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Carroll D; Translational Medicine, Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Singh M; Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Moschetta M; Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gutierrez PM; DMPK, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Gardelli C; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, AstraZeneca, Gothenburg, Sweden., Critchlow SE; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom., Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Fawell SE; Early Oncology, R&D, AstraZeneca, Waltham, United States., Barry ST; Bioscience, Early Oncology, R&D, AstraZeneca, Cambridge, United Kingdom. Larissa.Carnevalli@astrazeneca.com Simon.T.Barry@astrazeneca.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Jun; Vol. 20 (6), pp. 1080-1091. Date of Electronic Publication: 2021 Mar 30.
Autor:
Proia TA; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Singh M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Woessner R; Blueprint Medicines, Cambridge, Massachusetts., Carnevalli L; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Bommakanti G; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Magiera L; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Srinivasan S; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Grosskurth S; AbbVie, Lake County, Illinois., Collins M; Tufts University Graduate School of Biomedical Sciences, Medford, Massachusetts., Womack C; Womack Consulting, Stamford, UK., Griffin M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Ye M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Cantin S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Russell D; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Xie M; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Hughes A; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Deng N; GSK, Cambridge, Massachusetts., Mele DA; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Fawell S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Barry S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Reimer C; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Barrett JC; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., McCoon P; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts. patricia.mccoon@astrazeneca.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Dec 01; Vol. 26 (23), pp. 6335-6349. Date of Electronic Publication: 2020 Sep 17.
Autor:
Feng YX; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Sokol ES; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North CarolinaAuthors' Affiliations:Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Del Vecchio CA; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Sanduja S; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Claessen JH; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Proia TA; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Jin DX; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North CarolinaAuthors' Affiliations:Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Reinhardt F; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Ploegh HL; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North CarolinaAuthors' Affiliations:Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Wang Q; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North Carolina., Gupta PB; Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts; and Department of Chemistry, Duke University, Durham, North CarolinaAuthors' Affiliations:Whitehead Institute for Biomedical Research; Department of Biology, Massachusetts Institute of Technology; Koch Institute for Integrative Cancer Research; Harvard Stem Cell Institute; Broad Institute, Cambridge, Massachusetts pgupta@wi.mit.edu.
Publikováno v:
Cancer discovery [Cancer Discov] 2014 Jun; Vol. 4 (6), pp. 702-15. Date of Electronic Publication: 2014 Apr 04.
Autor:
Proia TA; Department of Anatomy & Cellular Biology, Sackler School of Biomedical Research, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111, USA., Keller PJ, Gupta PB, Klebba I, Jones AD, Sedic M, Gilmore H, Tung N, Naber SP, Schnitt S, Lander ES, Kuperwasser C
Publikováno v:
Cell stem cell [Cell Stem Cell] 2011 Feb 04; Vol. 8 (2), pp. 149-63.